Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Ascletis, CR Pharmaceutical partner to distribute HCV drug in Beijing

June 29, 2018 6:19 PM UTC

Ascletis Pharma Inc. (Hangzhou, China) partnered with the CR Pharmaceutical Commercial Group Co. Ltd. subsidiary of China Resources Pharmaceutical Group Ltd. (Beijing, China) to develop distribution networks and end-user services in Beijing for the launch of Ganovo danoprevir. China approved the HCV NS3/4A protease inhibitor in June to treat HCV infection (see “Chinese Approval for Ascletis’ HCV Drug")...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article